ID TE 159.T AC CVCL_1743 SY TE-159-T; TE-159.T; TE159T DR CLO; CLO_0009292 DR ArrayExpress; E-MTAB-2770 DR ATCC; CRL-7752 DR BioSample; SAMN03471147 DR BioSample; SAMN10988169 DR cancercelllines; CVCL_1743 DR Cell_Model_Passport; SIDM01761 DR Cosmic; 686755 DR DepMap; ACH-000175 DR IARC_TP53; 30179 DR LiGeA; CCLE_329 DR PharmacoDB; TE159_T_1572_2019 DR Progenetix; CVCL_1743 DR Wikidata; Q54971953 RX DOI=10.1101/166199; RX PubMed=12068308; RX PubMed=26589293; RX PubMed=30894373; RX PubMed=31068700; CC Problematic cell line: Misclassified. Originally thought to be a rhabdomyosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000175). CC Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). CC Population: Caucasian. CC HLA typing: A*02:01,11:01; B*15:01,52:01; C*04:01,12:02; DRB1*01:03,15:01 (PubMed=26589293). CC Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (DepMap=ACH-000175). CC Omics: Genomics; Whole exome sequencing. CC Omics: Transcriptomics; RNAseq. CC Genome ancestry: African=1.8%; Native American=21.64%; East Asian, North=2.4%; East Asian, South=0%; South Asian=1.76%; European, North=45.27%; European, South=27.14% (PubMed=30894373). CC Cell type: Fibroblast; CL=CL_0000057. ST Source(s): ATCC=CRL-7752 ST Amelogenin: X,Y ST CSF1PO: 12,13 ST D13S317: 12,14 ST D16S539: 9,11 ST D18S51: 16,21 ST D19S433: 13 ST D21S11: 28,30 ST D2S1338: 19,23 ST D3S1358: 14,15 ST D5S818: 9,11 ST D7S820: 10,11 ST D8S1179: 12,15 ST FGA: 23 ST Penta D: 10 ST Penta E: 12,16 ST TH01: 6,9.3 ST TPOX: 8,11 ST vWA: 17 OX NCBI_TaxID=9606; ! Homo sapiens (Human) SX Male AG 6Y CA Undefined cell line type DT Created: 04-04-12; Last updated: 14-08-25; Version: 28 // RX PubMed=12068308; DOI=10.1038/nature00766; RA Davies, Helen R. RA Bignell, Graham Robert RA Cox, Charles RA Stephens, Philip J. RA Edkins, Sarah RA Clegg, Sheila RA Teague, Jon W. RA Woffendin, Hayley RA Garnett, Mathew J. RA Bottomley, William RA Davis, Neil RA Dicks, Ed RA Ewing, Rebecca RA Floyd, Yvonne RA Gray, Kristian RA Hall, Sarah RA Hawes, Rachel RA Hughes, Jaime RA Kosmidou, Vivian RA Menzies, Andrew RA Mould, Catherine RA Parker, Adrian RA Stevens, Claire RA Watt, Stephen RA Hooper, Steven RA Wilson, Rebecca RA Jayatilake, Hiran RA Gusterson, Barry Austin RA Cooper, Colin S. RA Shipley, Janet M. RA Hargrave, Darren RA Pritchard-Jones, Kathryn RA Maitland, Norman J. RA Chenevix-Trench, Georgia RA Riggins, Gregory J. RA Bigner, Darell Doty RA Palmieri, Giuseppe RA Cossu, Antonio RA Flanagan, Adrienne Margaret RA Nicholson, Andrew RA Ho, Judy W.C. RA Leung, Suet Yi RA Yuen, Siu Tsan RA Weber, Barbara L. RA Seigler, Hilliard Foster RA Darrow, Timothy L. RA Paterson, Hugh F. RA Marais, Richard RA Marshall, Christopher John RA Wooster, Richard RA Stratton, Michael Rudolf RA Futreal, P. Andrew RT "Mutations of the BRAF gene in human cancer."; RL Nature 417:949-954(2002). // RX DOI=10.1101/166199; RA de Weck, Antoine RA Bitter, Hans RA Kauffmann, Audrey RT "Fibroblasts cell lines misclassified as cancer cell lines."; RL bioRxiv 2017:166199-166199(2017). // RX PubMed=31068700; DOI=10.1038/s41586-019-1186-3; PMCID=PMC6697103; RA Ghandi, Mahmoud RA Huang, Franklin W. RA Jane-Valbuena, Judit RA Kryukov, Gregory V. RA Lo, Christopher C. RA McDonald, E. Robert 3rd RA Barretina, Jordi Ginesta RA Gelfand, Ellen T. RA Bielski, Craig M. RA Li, Hao-Xin RA Hu, Kevin RA Andreev-Drakhlin, Alexander Y. RA Kim, Jaegil RA Hess, Julian M. RA Haas, Brian J. RA Aguet, Francois RA Weir, Barbara A. RA Rothberg, Michael V. RA Paolella, Brenton R. RA Lawrence, Michael Scott RA Akbani, Rehan RA Lu, Yi-Ling RA Tiv, Hong L. RA Gokhale, Prafulla C. RA de Weck, Antoine RA Mansour, Ali Amin RA Oh, Coyin RA Shih, Juliann RA Hadi, Kevin RA Rosen, Yanay RA Bistline, Jonathan RA Venkatesan, Kavitha RA Reddy, Anupama RA Sonkin, Dmitriy RA Liu, Manway RA Lehar, Joseph RA Korn, Joshua M. RA Porter, Dale A. RA Jones, Michael D. RA Golji, Javad RA Caponigro, Giordano RA Taylor, Jordan E. RA Dunning, Caitlin M. RA Creech, Amanda L. RA Warren, Allison C. RA McFarland, James M. RA Zamanighomi, Mahdi RA Kauffmann, Audrey RA Stransky, Nicolas RA Imielinski, Marcin RA Maruvka, Yosef E. RA Cherniack, Andrew D. RA Tsherniak, Aviad RA Vazquez, Francisca RA Jaffe, Jacob D. RA Lane, Andrew Alan RA Weinstock, David M. RA Johannessen, Cory M. RA Morrissey, Michael P. RA Stegmeier, Frank RA Schlegel, Robert RA Hahn, William Chun RA Getz, Gad RA Mills, Gordon B. RA Boehm, Jesse S. RA Golub, Todd Robert RA Garraway, Levi Alexander RA Sellers, William Raj RT "Next-generation characterization of the Cancer Cell Line RT Encyclopedia."; RL Nature 569:503-508(2019). // RX PubMed=26589293; DOI=10.1186/s13073-015-0240-5; PMCID=PMC4653878; RA Scholtalbers, Jelle RA Boegel, Sebastian RA Bukur, Thomas RA Byl, Marius RA Goerges, Sebastian RA Sorn, Patrick RA Loewer, Martin RA Sahin, Ugur RA Castle, John C. RT "TCLP: an online cancer cell line catalogue integrating HLA type, RT predicted neo-epitopes, virus and gene expression."; RL Genome Med. 7:118.1-118.7(2015). // RX PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747; PMCID=PMC6445675; RA Dutil, Julie RA Chen, Zhi-Hua RA Monteiro, Alvaro N.A. RA Teer, Jamie K. RA Eschrich, Steven A. RT "An interactive resource to probe genetic diversity and estimated RT ancestry in cancer cell lines."; RL Cancer Res. 79:1263-1273(2019). //